Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma

Documenta Ophthalmologica

Volumn 119, Issue 1, 2009, Pages 13-22

  Brodie, Scott E ^a,b,c   Pierre Gobin, Y ^c   Dunkel, Ira J ^a,c   Kim, Jonathan W ^a   Abramson, David H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Arterial infusion; Chemotherapy; Electroretinography; Melphalan; Retinal function; Retinoblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; MELPHALAN;

ADULT; ADVANCED CANCER; ARTERY CATHETERIZATION; ARTICLE; CANCER CHEMOTHERAPY; CATARACT; CHOROID MELANOMA; CLINICAL ARTICLE; CONJUNCTIVAL HYPEREMIA; DRUG RESPONSE; DRUG TISSUE LEVEL; ELECTRORETINOGRAPHY; ENUCLEATION; EYELID EDEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NEUTROPENIA; OPHTHALMIC ARTERY; PATIENT MONITORING; RADIATION INJURY; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINOBLASTOMA; RETINOPATHY; TUMOR REGRESSION; VISION;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARBOPLATIN; COHORT STUDIES; ELECTRORETINOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; INFANT; INFUSIONS, INTRA-ARTERIAL; MELPHALAN; OPHTHALMIC ARTERY; RETINA; RETINAL DETACHMENT; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 67649607489     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-008-9164-3     Document Type: Article

References (12)

1. Abramson DH (2005) Retinoblastoma in the 20th century: Past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci 46:2684-2691. doi: 10.1167/iovs.04-1462
2. Chantada MD, Dunkel IJ, Antoneli MD et al (2006) Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Pediatr Blood Cancer 49:256-260. doi: 10.1002/pbc.21067
3. Reese AB, Hyman G, Tapley NV et al (1958) The treatment of retinoblastoma by X-ray and triethylene melamine. Arch Ophthalmol 60:897-906
4. Kiribuchi M (1996) Retrograde infusion of anti-cancer drugs to ophthalmic artery for intraocular malignant tumors. Nippon Ganka Gakkai Zasshi 70(11):1829-1833 (in Japanese)
5. Kaneko A, Ise T, Oohira M et al (1990) Two cases of recurrent intraocular retinoblastoma treated with ocular thermochemotherapy. Clin Ophthalmol 44(3):289-292
6. Mohiri M (1993) The technique of selective ophthalmic arterial infusion for conservative treatment of recurrent retinoblastoma. Keio Igaku 70:679-687 (in Japanese)
7. Ueda M, Tanabe J, Inomata K et al (1995) Study on conservative treatment of retinoblastoma-effect of intravitreal injection of melphalan on the rabbit retina. J Jpn Ophthalmol Soc 99:1230-1235 (in Japanese)
8. Kaneko A, Suzuki S (2003) Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol 33(12):601-607. doi: 10.1093/ jjco/hyg113
9. Suzuki S, Kaneko A (2004) Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol 9:1-6. doi: 10.1007/s10147-003-0366-0
10. Kaneko A (1999) Japanese contribution to ocular oncology. Int J Clin Oncol 4:321-326. doi: 10.1007/s101470050078
11. Abramson DH, Dunkel I, Brodie SE, Kim JW, Gobin YP, Phase A (2008) I/II Study of direct interarterial (ophthalmic artery) melphalan for intraocular retinoblastoma: Preliminary results. Ophthalmology 115(8):1398-1404. doi: 10.1016/j.ophtha.2007.12.014
12. Marmor MF, Holder GE, Seeliger MW, Yamamoto S (2004) Standard for clinical electroretinography (2004 update). Doc Ophthalmol 108:107-114. doi: 10.1023/B:DOOP.0000036793.44912.45